Xinyue Liu

Epidemiologist
Merck and Co., Inc., Kenilworth, New Jersey, USA

Poster(s):

• (V) Regulatory Benefit-Risk Assessment of Oncology Drugs: A Systematic Review of FDA and EMA Approvals
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (163) Colorectal Cancer Cohort Comparison Among Four Real-World Databases
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (68) Use of Symptomatic Treatments for Alzheimer's Disease Dementia
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST